AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

CNBX Pharmaceuticals Inc.

$0 -$0.00 (-75.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
9.25K
AVG Volume
15.61M
Trailing/Forward PE
-0.5/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
-20K020K40K60K24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q30
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q4-17.57K
24 Q317.57K
24 Q240.64K
Net Income (USD)
-400K-300K-200K-100K024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q3-154.16K
26 Q2-44.1K
26 Q1-113.72K
25 Q4-150.11K
25 Q3-59.73K
25 Q2-69.79K
25 Q1-34.35K
24 Q4-60.58K
24 Q3-131K
24 Q2-325K
Operating Income (USD)
-300K-200K-100K024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q3-162.76K
26 Q2-72.96K
26 Q1-64K
25 Q4-129.73K
25 Q3-40.38K
25 Q2-64.74K
25 Q1-36.84K
24 Q4-52.53K
24 Q3-152K
24 Q2-206K
EBITDA (USD)
-200K-150K-100K-50K024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q3-162.76K
26 Q2-72.96K
26 Q1-64K
25 Q4-131.83K
25 Q3-40.38K
25 Q2-64.74K
25 Q1-36.84K
24 Q4-52.53K
24 Q3-152K
24 Q2-174K
Cash Flows (USD)
-150K-100K-50K050K24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q3-47.67K
26 Q2-30.55K
26 Q1-47.41K
25 Q4-28.55K
25 Q3-52.02K
25 Q2-51.66K
25 Q1-39.08K
24 Q4-48.25K
24 Q3225
24 Q2-124.4K
EPS (USD)
-0.01-0.01-0024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX EPS (USD) by quarter
PeriodEPS (USD)
26 Q30
26 Q20
26 Q1-0
25 Q40
25 Q3-0
25 Q2-0
25 Q1-0
24 Q4-0
24 Q3-0
24 Q2-0.01
Expenses (USD)
-100K0100K200K300KR&DSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q3162.77K
26 Q272.96K
26 Q164K
25 Q4129.73K
25 Q340.38K
25 Q264.74K
25 Q136.84K
24 Q451.34K
24 Q3152.28K
24 Q2207.99K
Cash & Debt (USD)
0500K1M1.5MCashShort Term Debt24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q39.49K
26 Q212.15K
26 Q17.7K
25 Q415.11K
25 Q313.65K
25 Q245.67K
25 Q117.34K
24 Q426.42K
24 Q373.41K
24 Q237.14K
Debt ratios
-8-6-4-2024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX Debt ratios by quarter
PeriodDebt ratios
26 Q3-0.26
26 Q2-0.2
26 Q1-4.12
25 Q4-4.32
25 Q3-6.82
25 Q2-4.42
25 Q1-3.16
24 Q4-2.48
24 Q3-0.36
24 Q2-0.38
Margins
-200%0%200%400%20 Q220 Q320 Q422 Q423 Q323 Q424 Q124 Q224 Q324 Q4
CNBX Margins by quarter
PeriodMargins
24 Q4393.31%
24 Q3100%
24 Q284.69%
24 Q155.88%
23 Q461.51%
23 Q387.11%
22 Q4-157.85%
20 Q4100%
20 Q3100.21%
20 Q2100%
Return on Capital
0%5%10%15%24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX Return on Capital by quarter
PeriodReturn on Capital
26 Q35.8%
26 Q21.74%
26 Q14.42%
25 Q46.01%
25 Q32.35%
25 Q22.71%
25 Q11.37%
24 Q42.44%
24 Q35.34%
24 Q213.78%
Shares Outstanding
0500M1B1.5B24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX Shares Outstanding by quarter
PeriodShares Outstanding
26 Q31.32B
26 Q2931.02M
26 Q1732.86M
25 Q4553.96M
25 Q342.6M
25 Q232.1M
25 Q131.11M
24 Q431.11M
24 Q331.11M
24 Q230.99M
Book Value Per Share (USD)
-0.1-0.08-0.05-0.03-024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q3-0
26 Q2-0
26 Q1-0
25 Q4-0
25 Q3-0.06
25 Q2-0.08
25 Q1-0.08
24 Q4-0.08
24 Q3-0.08
24 Q2-0.08
Total Assets (USD)
050K100K150K200K24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
CNBX Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q312.79K
26 Q214.9K
26 Q111.16K
25 Q418.44K
25 Q318.61K
25 Q250.66K
25 Q122.31K
24 Q431.38K
24 Q380.03K
24 Q2163.92K
Employee Count
0510152016201720182019202020212022202320242025
CNBX Employee Count by quarter
PeriodEmployee Count
20251
20242
20232
20225
202110
20209
201911
20188
20175
20162
PE Ratio
010203040med 19.59May 19Jun 19Jul 19Sep 19Oct 19Nov 19Jan 20
CNBX PE Ratio by quarter
PeriodPE Ratio
Jan 2032.98
Jan 2015.31
Dec 199.42
Dec 1911.78
Dec 1912.37
Dec 1914.13
Nov 1917.67
Nov 199.8
Nov 199.8
Nov 1910.55
Nov 1912.06
Oct 1915.72
Oct 1915.82
Oct 1918.08
Oct 1915.82
Sep 1915.82
Sep 1919.59
Sep 1915.07
Sep 1915.82
Aug 1919.59
Aug 1920.35
Aug 1919.03
Aug 1920.35
Aug 1921.85
Jul 1921.1
Jul 1924.11
Jul 1924.59
Jul 1922.13
Jun 1922.95
Jun 1923.77
Jun 1923.77
Jun 1927.04
May 1926.23
May 1926.23
May 1926.23
May 1927.87
May 1927.87
Apr 1927.05
Apr 1929.51
Free Cash Flow Yield
-15000%-10000%-5000%0%med -116.92%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CNBX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-116.92%
Sep 26-116.92%
Aug 26-83.51%
Aug 26-77.95%
Aug 26-77.95%
Aug 26-77.95%
Jul 26-116.92%
Jul 26-11691.92%
Jul 26-116.92%
Jul 26-116.92%
Jul 26-77.95%
Jun 26-58.46%
Jun 26-113.51%
Jun 26-85.13%
Jun 26-85.13%
May 26-85.13%
May 26-68.11%
May 26-85.13%
May 26-56.76%
May 26-68.11%
Apr 26-48.65%
Apr 26-170.27%
Apr 26-122.56%
Apr 26-245.12%
Mar 26-245.12%
Mar 26-245.12%
Mar 26-163.41%
Mar 26-122.56%
Feb 26-122.56%
Feb 26-163.41%
Feb 26-163.41%
Feb 26-122.56%
Jan 26-163.41%
Jan 26-122.56%
Jan 26-61.28%
Jan 26-61.85%
Jan 26-77.31%
Dec 25-68.72%
Dec 25-77.31%
Dec 25-61.85%
Dec 25-77.31%
Nov 25-1121.02%
Nov 25-1281.16%
Nov 25-1494.69%
Nov 25-1281.16%
Oct 25-1121.02%
Oct 25-1281.16%
Oct 25-896.82%
Oct 25-1281.16%
Oct 25-1494.69%
Sep 25-1494.69%
Sep 25-1494.69%
Sep 25-1494.69%
Sep 25-1121.02%
Aug 25-896.82%
Aug 25-747.35%
Aug 25-1281.16%
Aug 25-896.82%
Aug 25-896.82%
Jul 25-659.42%
Jul 25-747.35%
Jul 25-720.56%
Jul 25-480.37%
Jun 25-480.37%
Jun 25-393.03%
Jun 25-432.34%
Jun 25-308.81%
May 25-320.25%
May 25-288.22%
May 25-360.28%
May 25-216.17%
May 25-144.11%
Apr 25-101.73%
Apr 25-45.99%
Apr 25-97.12%
Apr 25-89.45%
Mar 25-89.45%
Mar 25-88.52%
Mar 25-88.75%
Mar 25-70.52%
Feb 25-67.98%
Feb 25-67.98%
Feb 25-67.98%
Feb 25-67.98%
Jan 25-63.53%
Jan 25-89.45%
Jan 25-75.54%
Jan 25-109.58%
Jan 25-102.47%
Dec 24-78.9%
Dec 24-131.5%
Dec 24-78.9%
Dec 24-87.67%
Nov 24-105.2%
Nov 24-55.68%
Nov 24-70.12%
Nov 24-48.96%
Nov 24-65.28%
Oct 24-41.31%
Oct 24-47.17%
Price to Sales
-2.502.557.510med 0.71Dec 23Mar 24Jul 24Oct 24Jan 25Aug 25Nov 25
CNBX Price to Sales by quarter
PeriodPrice to Sales
Nov 25-0.97
Nov 25-0.85
Nov 25-0.73
Nov 25-0.85
Oct 25-0.97
Oct 25-0.85
Oct 25-1.21
Oct 25-0.85
Oct 25-0.73
Sep 25-0.73
Sep 25-0.73
Sep 25-0.73
Sep 25-0.97
Aug 25-1.21
Aug 25-1.45
Aug 25-0.85
Aug 25-1.21
Aug 25-1.21
Jul 25-1.65
Jul 25-1.45
Apr 255.36
Apr 255.82
Mar 255.82
Mar 255.88
Mar 255.86
Mar 257.38
Feb 257.66
Feb 257.66
Feb 257.66
Feb 257.66
Jan 258.19
Jan 255.82
Jan 256.89
Jan 251.72
Jan 251.84
Dec 242.39
Dec 241.44
Dec 242.39
Dec 242.15
Nov 241.79
Nov 241.28
Nov 241.02
Nov 241.46
Nov 241.09
Oct 241.73
Oct 241.51
Oct 241.05
Oct 240.92
Sep 240.89
Sep 240.89
Sep 240.93
Sep 240.94
Aug 240.78
Aug 240.7
Aug 240.93
Aug 240.65
Aug 240.94
Jul 240.88
Jul 240.73
Jul 240.41
Jul 240.4
Jun 240.33
Jun 240.46
Jun 240.54
Jun 240.46
May 240.52
May 240.56
May 240.64
May 240.59
May 240.65
Apr 240.62
Apr 240.65
Apr 240.83
Apr 240.61
Mar 240.88
Mar 240.76
Mar 240.83
Mar 240.72
Mar 240.61
Feb 240.66
Feb 240.83
Feb 240.73
Feb 240.62
Jan 240.72
Jan 240.87
Jan 240.89
Jan 240.83
Dec 230.78
Dec 230.66
Dec 230.69
Dec 230.66
Dec 230.72
Nov 230.33
Nov 230.38
Nov 230.34
Nov 230.49
Oct 230.44
Oct 230.46
Oct 230.53
Oct 230.41
EV/EBITDA
0204060med 21.65Jan 20Feb 20Apr 20Jun 20Jul 20Sep 20Oct 20
CNBX EV/EBITDA by quarter
PeriodEV/EBITDA
Oct 2018.24
Oct 2017.26
Oct 2014.82
Oct 2014.85
Oct 2015.58
Sep 2015.01
Sep 2016.8
Sep 2016.34
Sep 2016.85
Aug 2018.85
Aug 2018.59
Aug 2018.8
Aug 2019.41
Jul 2019.42
Jul 2022.99
Jul 2021.46
Jul 2022.76
Jul 2024.99
Jun 2021.65
Jun 2028.33
Jun 2030.56
Jun 2027.22
May 2028.33
May 2027.22
May 2022.76
May 2021.65
May 2022.76
Apr 2026.1
Apr 2032.78
Apr 2016.91
Apr 2015.77
Mar 2022.58
Mar 2024.85
Mar 2032.8
Mar 2038.47
Feb 2031.66
Feb 2041.88
Feb 2039.61
Feb 2041.88
Jan 2056.63
Jan 2042.22
Jan 2043.01
Jan 2025.28
Jan 2010.33
Dec 195.34
Dec 197.34
Dec 197.84
Dec 199.33
Nov 1912.32
Price to Book
0204060med 9.33Jul 20Oct 20Feb 21May 21Sep 21Dec 21Apr 22
CNBX Price to Book by quarter
PeriodPrice to Book
Apr 220.14
Apr 2218.4
Mar 2218.81
Mar 2214.25
Mar 2214.67
Mar 2216.39
Feb 2216.72
Feb 2216.72
Feb 220.15
Feb 2217.66
Jan 2220.29
Jan 220.2
Jan 220.19
Jan 220.07
Dec 217.13
Dec 216.81
Dec 218.4
Dec 218.41
Dec 2110
Nov 217.95
Nov 218.01
Nov 218.16
Nov 218.27
Oct 218.74
Oct 218.74
Oct 218.15
Oct 218.53
Oct 219.18
Sep 219.89
Sep 219.03
Sep 219.83
Sep 219.38
Aug 219.61
Aug 219.28
Aug 219.9
Aug 2110.15
Jul 219.78
Jul 219.89
Jul 2110.19
Jul 216.69
Jul 216.58
Jun 216.44
Jun 217.11
Jun 216.88
Jun 216.79
May 216.94
May 216.79
May 216.97
May 217.39
Apr 216.97
Apr 216.58
Apr 216.36
Apr 2126.9
Apr 2127.97
Mar 2129.04
Mar 2138.72
Mar 2142.71
Mar 2141.3
Feb 2146.26
Feb 2151.64
Feb 2140.89
Feb 2150.03
Jan 2130.13
Jan 2133.41
Jan 2134.96
Jan 2117.99
Dec 2015.86
Dec 2020.54
Dec 2020.57
Dec 2022.09
Dec 2022.84
Nov 2022.09
Nov 2021.36
Nov 2014.47
Nov 2013.72
Oct 204.99
Oct 204.74
Oct 204.11
Oct 204.12
Oct 204.31
Sep 204.16
Sep 204.62
Sep 204.5
Sep 204.63
Aug 205.15
Aug 205.08
Aug 205.14
Aug 205.3
Jul 205.3
Jul 206.22
Jul 205.83
Jul 209.41
Jul 2010.26
Jun 208.98
Jun 2011.54
Jun 2012.4
Jun 2011.12
May 2011.54
May 2011.12
May 209.41
CNBX Pharmaceuticals Inc.
CNBX
Stockpicker

Video analysis: CNBX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.